Advertisement

Ads Placeholder
Loading...

Harrow Health, Inc.

HROW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$35.31
$-0.12(-0.34%)
U.S. Market opens in 0h 55m

Harrow Health, Inc. (HROW) Stock Overview

Explore Harrow Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E Ratio-252.58
EPS (TTM)$-0.14
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$37.96
3 Months$33.68
1 Year Target$52.33

HROW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harrow Health, Inc. (HROW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $52.33.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -252.58 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.34%
5-Day Change
0.20%
1-Month Change
-8.52%
3-Month Change
-29.25%
6-Month Change
-22.28%
Year-to-Date (YTD) Change
-29.25%
1-Year Change
46.76%
3-Year Change
68.38%
5-Year Change
428.59%
All-Time (Max) Change
37.88%

Contact Information

https://www.harrowinc.com
615 733 4730
102 Woodmont Boulevard, Nashville, TN, 37205

Company Facts

3,820 Employees
IPO DateSep 28, 2007
CountryUS
Actively Trading

Frequently Asked Questions